NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/02/2023
Back to search
Official data from USPTO
ON DEMAND PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/02/2023
Trademark type
Combined
Nice classes
7, 40
Filing date
05/14/2021
Registration date
05/02/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
05/02/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2016-01-00
First use in commerce
2016-01-00
Drawing code
5
Owner type
03
Owner location
Rockville, MD
Examiner
WATSON, BRIDGET
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "ON DEMAND PHARMACEUTICALS" in a stylized form.
Holders and representatives
Holders
On Demand Pharmaceuticals, Inc.
Representatives
Daniel P. Mullarkey Polsinelli PC
Technical classification
Nice Classes
Class 7Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
Machines for manufacturing pharmaceuticalspharmaceutical production machines for producing all types of medicine and parts and fittings thereof
Class 40
Custom manufacturing of pharmaceutical processing machines and apparatus
Publications
History of USPTO decisions and trademark events.
32 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/02/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2023
ALIE
ASSIGNED TO LIE
03/29/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/12/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
02/28/2023
IUAA
USE AMENDMENT ACCEPTED
02/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/21/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/17/2023
IUAF
USE AMENDMENT FILED
02/17/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/16/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/10/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/23/2022
GNFR
FINAL REFUSAL E-MAILED
08/23/2022
CNFR
FINAL REFUSAL WRITTEN
08/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/28/2022
GNRT
NON-FINAL ACTION E-MAILED
01/28/2022
CNRT
NON-FINAL ACTION WRITTEN
01/28/2022
DOCK
ASSIGNED TO EXAMINER
01/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/13/2021
NWAP
NEW APPLICATION ENTERED
05/18/2021
Continuous trademark protection
Get notified about every new filing that threatens ON DEMAND PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.